Cryo-electron microscopy of adeno-associated virus
SM Stagg, C Yoshioka, O Davulcu… - Chemical …, 2022 - ACS Publications
Adeno-associated virus (AAV) has a single-stranded DNA genome encapsidated in a small
icosahedrally symmetric protein shell with 60 subunits. AAV is the leading delivery vector in …
icosahedrally symmetric protein shell with 60 subunits. AAV is the leading delivery vector in …
AAV vectors vaccines against infectious diseases
K Nieto, A Salvetti - Frontiers in immunology, 2014 - frontiersin.org
Since their discovery as a tool for gene transfer, vectors derived from the adeno-associated
virus (AAV) have been used for gene therapy applications and attracted scientist to this field …
virus (AAV) have been used for gene therapy applications and attracted scientist to this field …
[HTML][HTML] Understanding AAV vector immunogenicity: from particle to patient
BP Dhungel, I Winburn, C da Fonseca Pereira… - Theranostics, 2024 - ncbi.nlm.nih.gov
Gene therapy holds promise for patients with inherited monogenic disorders, cancer, and
rare genetic diseases. Naturally occurring adeno-associated virus (AAV) offers a well-suited …
rare genetic diseases. Naturally occurring adeno-associated virus (AAV) offers a well-suited …
Viral vectors as vaccine carriers
HCJ Ertl - Current Opinion in Virology, 2016 - Elsevier
Highlights•Ad vectors are highly immunogenic and thus superb vaccine carriers.•Most AAVs
are poorly immunogenic and thus more suited for gene replacement therapy.•Pre-existing …
are poorly immunogenic and thus more suited for gene replacement therapy.•Pre-existing …
PCR-based analytical methods for quantification and quality control of recombinant adeno-associated viral vector preparations
AA Shmidt, TV Egorova - Pharmaceuticals, 2021 - mdpi.com
Recombinant adeno-associated viral vectors (rAAV) represent a gene therapy tool of ever-
increasing importance. Their utilization as a delivery vehicle for gene replacement, silencing …
increasing importance. Their utilization as a delivery vehicle for gene replacement, silencing …
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
The SARS-CoV-2 pandemic has affected more than 185 million people worldwide resulting
in over 4 million deaths. To contain the pandemic, there is a continued need for safe …
in over 4 million deaths. To contain the pandemic, there is a continued need for safe …
Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens
T Wang, L Zheng, Q Zhao, Y Yao… - Journal of Medical …, 2023 - Wiley Online Library
Abstract Parainfluenza virus 5 (PIV5) is a negative‐sense, single‐stranded RNA virus that
can infect humans and many species of animals. Infection in these reservoir hosts is …
can infect humans and many species of animals. Infection in these reservoir hosts is …
HIV epidemic in Asia: implications for HIV vaccine and other prevention trials
N Phanuphak, YR Lo, Y Shao, SS Solomon… - AIDS research and …, 2015 - liebertpub.com
An overall decrease of HIV prevalence is now observed in several key Asian countries due
to effective prevention programs. The decrease in HIV prevalence and incidence may further …
to effective prevention programs. The decrease in HIV prevalence and incidence may further …
Novel directions in HIV-1 vaccines revealed from clinical trials
JL Excler, GD Tomaras, ND Russell - Current opinion in HIV and …, 2013 - journals.lww.com
Future efficacy trials will focus on prevention of HIV-1 transmission in heterosexual
population in Africa and MSM in Asia. The recent successes leading to novel directions in …
population in Africa and MSM in Asia. The recent successes leading to novel directions in …
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers
Study Design A randomized, double-blind, placebo controlled phase I trial. Methods The trial
was conducted in 32 HIV-uninfected healthy volunteers to assess the safety and …
was conducted in 32 HIV-uninfected healthy volunteers to assess the safety and …